We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exposure Therapy for Fear of Falling in Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01609322
Recruitment Status : Completed
First Posted : May 31, 2012
Last Update Posted : December 23, 2013
Sponsor:
Collaborator:
Information provided by (Responsible Party):

May 29, 2012
May 31, 2012
December 23, 2013
August 2010
August 2013   (Final data collection date for primary outcome measure)
  • Fear of falling [ Time Frame: 2 months (primary) ]
    Fear of Falling will be measured using the Falls Efficacy Scale - International (FES-I), a version of the most widely used measure of falls self-efficacy. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point). We will also collect data at 5 months (3 month follow-up) and 8 months (6 month follow-up).
  • Activity avoidance [ Time Frame: 2 months (primary) ]
    Activity avoidance will be assessed using a modified version of the Activity Card Sort, a set of photographs of older adults engaged in various activities that is used in rehabilitation settings. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point), 5 months (3 month follow-up), and 8 months (6 month follow-up).
  • Fear of falling [ Time Frame: 2 months (primary) ]
    Fear of Falling will be measured using the Falls Efficacy Scale - International (FES-I), a version of the most widely used measure of falls self-efficacy. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point). We will also collect data at 5 months (3 month follow-up) and 8 months (6 month follow-up).
  • Activity avoidance [ Time Frame: 2 months (primary) ]
    Activity avoidance will be assessed using a modified version of the Activity Card Sort, a set of photographs of older adults engaged in various activities that is used in rehabilitation ssettings. Assessments are performed at baseline, 1 month, 2 months (end of intervention - primary outcome point), 5 months (3 month follow-up), and 8 months (6 month follow-up).
Complete list of historical versions of study NCT01609322 on ClinicalTrials.gov Archive Site
  • Physical activity - self-report [ Time Frame: 2 months (primary) ]
    Self-reported physical activity will be assessed with the Physical Activities Scale for the Elderly (PASE).
  • Physical activity [ Time Frame: 2 months ]
    Accelerometers will also be used to measure physical activity. Patients in the study will wear an Actigraph battery-operated activity monitor worn around the waist to measure physical activity continuously during waking hours. Assessment will occur before and after the intervention.
  • Physical Performance [ Time Frame: 2 months (primary) ]
    Physical performance will be measured using the Short Physical Performance Battery (SPPB), which includes measured of balance, walking, and lower body strength.
  • Quality of Life [ Time Frame: 2 months (primary) ]
    Quality of life will be measured with the Quality of Life Inventory (QOLI).
  • Depressive and Anxiety symptoms [ Time Frame: 2 months (primary) ]
    Depressive and anxiety symptoms will be assessed with the Hospital Anxiety and Depression Scale (HADS), a 14-item self-report measure with subscales assessing depressive and anxiety symptoms that does not include somatic items such as fatigue that can be associated with aging or medical conditions rather than psychiatric disorders.
  • Agoraphobic Avoidance [ Time Frame: 2 months (primary) ]
    Agoraphobic avoidance will be measured using the 5-item agoraphobia subscale of the Fear Questionaire (FQ).
  • Post Traumatic Stress Disorder Symptoms [ Time Frame: 2 months (primary) ]
    Post Traumatic Stress Disorder (PTSD) symptoms will be measured with the 6-item abbreviated form of the PTSD Checklist (PCL).
  • Fear of Falling [ Time Frame: 2 months (primary) ]
    Fear of falling will be measured using the Falling Questionaire, a 15-item survey assessing attitudes towards falling.
  • Avoidance [ Time Frame: 2 months (primary) ]
    Avoidance of activities will be measured using the Fear of Falling Avoidance-Behavior Questionaire (FFABQ), a 14-item measure to assess avoidance behaviors.
  • Falls [ Time Frame: 2 months (primary) ]
    Recorded on fall diaries provided to investigators throughout the 2-month intervention and 6-month follow-up period.
Same as current
Not Provided
Not Provided
 
Exposure Therapy for Fear of Falling in Older Adults
Exposure Therapy for Fear of Falling in Older Adults
This project aims to test the efficacy of an in-home intervention, "Activity, Balance, Learning, and Exposure" (ABLE), which integrates exposure therapy with cognitive restructuring, exercise, and home safety evaluation for older adults with excessive fear of falling. The intervention will be conducted by a licensed physical therapist. A control intervention will be conducted by a health educator. The specific aims of the study are to test the feasibility, acceptability, tolerability, and safety of the ABLE intervention.

Approximately 7-14% of older adults living independently in the community, including more than 5% of those who have never experienced a fall, experience moderate to severe fear of falling. Fear of falling leads to decreased physical activity, disability, loss of independence, depression, anxiety, reduced social engagement, and poor quality of life. It is also a major independent risk factor for falls.

Interventions targeting fear of falling, typically delivered in groups and incorporating cognitive restructuring, education, and exercise, have been shown to increase fall-related self-efficacy. Avoidance is resistant to treatment, however, and more than one-third of patients enrolled in these interventions drop out. Factors associated with attrition include high levels of fear and avoidance, indicating that the individuals most in need of such programs are those most likely to withdraw prematurely. These data suggest that avoidance should be targeted in treatment, and that interventions should be designed to reach very fearful individuals who are most likely to drop out of traditional fear of falling programs.

Participation in this study will last up to 8 months. Participants will be randomly assigned to receive either the ABLE intervention or an education control condition. The control condition will consist of in-person education about falls to control for the time and attention provided in the ABLE arm.

Interventional
Phase 2
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Fear of Falling
  • Behavioral: Activity, Balance, Learning, and Exposure
    An in-home intervention that integrates exposure therapy with cognitive restructuring, exercise, and a home safety evaluation.
  • Behavioral: Fall prevention education
    In-home, individual sessions with a health educator regarding fall prevention
  • Active Comparator: Education about falls
    In-person education about falls with a health educator.
    Intervention: Behavioral: Fall prevention education
  • Experimental: Activity, Balance, Learning, and Exposure
    Intervention combining medication review, exercise, home safety evaluation, and exposure therapy.
    Intervention: Behavioral: Activity, Balance, Learning, and Exposure
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
40
August 2013
August 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  1. Age 65 years old or older.
  2. Severe fear as measured by a brief FES-I score > or = 13.
  3. Low to moderate actual risk of falls as set out in Lamb et al. (2008).
  4. Distress or functional impairment due to fear of falling.
  5. Approval from the patient's primary health care provider.

Exclusion Criteria:

  1. Medical condition that would interfere with the safe conduct of the intervention or compromise study participation.
  2. Bedbound, wheelchair-dependent, paralyzed in the lower extremities, or requiring the assistance of another person to transfer, walk, or perform intervention exercises within the home.
  3. Dementia or cognitive impairment as measured by a score above 10 on the Blessed Orientation Memory Test.
  4. Corrected visual acuity < 20/60.
  5. Current participation in psychotherapy or professional rehabilitation services (PT, OT) or in the process of being referred or evaluated for such services. Patients who develop a need for such services during their participation will complete an assessment prior to commencing the outside therapy but will be allowed to continue in the study.
  6. Active suicidal ideation
  7. Lifetime diagnosis of bipolar I or II disorder or any psychotic disorder.
  8. Alcohol or other substance abuse or dependence within six months.
  9. Psychosocial factors that would compromise study participation (e.g. homelessness, no telephone).
  10. History of osteoporotic fracture.
  11. Experiencing 3 or more falls in the past year.
  12. Body Mass Index of 17.0 or under.
  13. Significant orthostasis, defined as a 20 point or greater difference between seated and standing blood pressure, either systolic or diastolic.
Sexes Eligible for Study: All
65 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01609322
R34MH086668( U.S. NIH Grant/Contract )
R34MH086668 ( U.S. NIH Grant/Contract )
Yes
Not Provided
Not Provided
Julie Wetherell, University of California, San Diego
University of California, San Diego
National Institute of Mental Health (NIMH)
Principal Investigator: Julie Wetherell, PhD UCSD
University of California, San Diego
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP